Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina

G. G. Neri Serneri, G. F. Gensini, L. Poggesi, F. Trotta, P. A. Modesti, M. Boddi, A. Ieri, M. Margheri, G. C. Casolo, M. Bini, C. Rostagno, M. Carnovali, R. Abbate

Research output: Contribution to journalArticle

Abstract

399 out of 474 inpatients with unstable angina were monitored for 48 h and 97 of these were found to be refractory to conventional antianginal treatments and entered a randomised double-blind study. With the initial protocol heparin infusion or bolus were compared with aspirin; with a modified protocol, heparin infusion, the best of these three treatments, was compared with alteplase. Patients were monitored for 3 days after starting treatment and then observed clinically for 4 more days. On the first days of treatment heparin infusion significantly decreased the frequency of angina (by 84-94%), episodes of silent ischaemia (by 71-77%), and the overall duration of ischaemia (by 81-86%). Heparin bolus and aspirin were not effective. Alteplase caused small (non-significant) reductions on the first day only. Only minor bleeding complications occurred.

Original languageEnglish
Pages (from-to)615-618
Number of pages4
JournalLancet
Volume335
Issue number8690
DOIs
Publication statusPublished - Mar 17 1990

Fingerprint

Unstable Angina
Tissue Plasminogen Activator
Aspirin
Myocardial Ischemia
Heparin
Ischemia
Therapeutics
Double-Blind Method
Inpatients
Hemorrhage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Neri Serneri, G. G., Gensini, G. F., Poggesi, L., Trotta, F., Modesti, P. A., Boddi, M., ... Abbate, R. (1990). Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet, 335(8690), 615-618. https://doi.org/10.1016/0140-6736(90)90407-V

Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. / Neri Serneri, G. G.; Gensini, G. F.; Poggesi, L.; Trotta, F.; Modesti, P. A.; Boddi, M.; Ieri, A.; Margheri, M.; Casolo, G. C.; Bini, M.; Rostagno, C.; Carnovali, M.; Abbate, R.

In: Lancet, Vol. 335, No. 8690, 17.03.1990, p. 615-618.

Research output: Contribution to journalArticle

Neri Serneri, GG, Gensini, GF, Poggesi, L, Trotta, F, Modesti, PA, Boddi, M, Ieri, A, Margheri, M, Casolo, GC, Bini, M, Rostagno, C, Carnovali, M & Abbate, R 1990, 'Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina', Lancet, vol. 335, no. 8690, pp. 615-618. https://doi.org/10.1016/0140-6736(90)90407-V
Neri Serneri GG, Gensini GF, Poggesi L, Trotta F, Modesti PA, Boddi M et al. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet. 1990 Mar 17;335(8690):615-618. https://doi.org/10.1016/0140-6736(90)90407-V
Neri Serneri, G. G. ; Gensini, G. F. ; Poggesi, L. ; Trotta, F. ; Modesti, P. A. ; Boddi, M. ; Ieri, A. ; Margheri, M. ; Casolo, G. C. ; Bini, M. ; Rostagno, C. ; Carnovali, M. ; Abbate, R. / Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. In: Lancet. 1990 ; Vol. 335, No. 8690. pp. 615-618.
@article{977b0b51c23f49d9870080a4ff8343dc,
title = "Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina",
abstract = "399 out of 474 inpatients with unstable angina were monitored for 48 h and 97 of these were found to be refractory to conventional antianginal treatments and entered a randomised double-blind study. With the initial protocol heparin infusion or bolus were compared with aspirin; with a modified protocol, heparin infusion, the best of these three treatments, was compared with alteplase. Patients were monitored for 3 days after starting treatment and then observed clinically for 4 more days. On the first days of treatment heparin infusion significantly decreased the frequency of angina (by 84-94{\%}), episodes of silent ischaemia (by 71-77{\%}), and the overall duration of ischaemia (by 81-86{\%}). Heparin bolus and aspirin were not effective. Alteplase caused small (non-significant) reductions on the first day only. Only minor bleeding complications occurred.",
author = "{Neri Serneri}, {G. G.} and Gensini, {G. F.} and L. Poggesi and F. Trotta and Modesti, {P. A.} and M. Boddi and A. Ieri and M. Margheri and Casolo, {G. C.} and M. Bini and C. Rostagno and M. Carnovali and R. Abbate",
year = "1990",
month = "3",
day = "17",
doi = "10.1016/0140-6736(90)90407-V",
language = "English",
volume = "335",
pages = "615--618",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Lancet Publishing Group",
number = "8690",

}

TY - JOUR

T1 - Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina

AU - Neri Serneri, G. G.

AU - Gensini, G. F.

AU - Poggesi, L.

AU - Trotta, F.

AU - Modesti, P. A.

AU - Boddi, M.

AU - Ieri, A.

AU - Margheri, M.

AU - Casolo, G. C.

AU - Bini, M.

AU - Rostagno, C.

AU - Carnovali, M.

AU - Abbate, R.

PY - 1990/3/17

Y1 - 1990/3/17

N2 - 399 out of 474 inpatients with unstable angina were monitored for 48 h and 97 of these were found to be refractory to conventional antianginal treatments and entered a randomised double-blind study. With the initial protocol heparin infusion or bolus were compared with aspirin; with a modified protocol, heparin infusion, the best of these three treatments, was compared with alteplase. Patients were monitored for 3 days after starting treatment and then observed clinically for 4 more days. On the first days of treatment heparin infusion significantly decreased the frequency of angina (by 84-94%), episodes of silent ischaemia (by 71-77%), and the overall duration of ischaemia (by 81-86%). Heparin bolus and aspirin were not effective. Alteplase caused small (non-significant) reductions on the first day only. Only minor bleeding complications occurred.

AB - 399 out of 474 inpatients with unstable angina were monitored for 48 h and 97 of these were found to be refractory to conventional antianginal treatments and entered a randomised double-blind study. With the initial protocol heparin infusion or bolus were compared with aspirin; with a modified protocol, heparin infusion, the best of these three treatments, was compared with alteplase. Patients were monitored for 3 days after starting treatment and then observed clinically for 4 more days. On the first days of treatment heparin infusion significantly decreased the frequency of angina (by 84-94%), episodes of silent ischaemia (by 71-77%), and the overall duration of ischaemia (by 81-86%). Heparin bolus and aspirin were not effective. Alteplase caused small (non-significant) reductions on the first day only. Only minor bleeding complications occurred.

UR - http://www.scopus.com/inward/record.url?scp=0025348126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025348126&partnerID=8YFLogxK

U2 - 10.1016/0140-6736(90)90407-V

DO - 10.1016/0140-6736(90)90407-V

M3 - Article

C2 - 1969013

AN - SCOPUS:0025348126

VL - 335

SP - 615

EP - 618

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8690

ER -